MIVI Neuroscience Announces First Patient Enrolled in EVAQ Clinical Study for Ischemic Stroke Treatment ...Middle East

EDEN PRAIRIE, Minn., Dec. 1, 2020 /PRNewswire/ -- MIVI Neuroscience, Inc. announced that it has enrolled the first patient in the Food and Drug Administration approved Investigational Device Exemption EVAQ Clinical Study. The procedure took place at Hôpital de Purpan in Toulouse, France....

Hence then, the article about mivi neuroscience announces first patient enrolled in evaq clinical study for ischemic stroke treatment was published today ( Wednesday 02/12/2020 - 05:15 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( MIVI Neuroscience Announces First Patient Enrolled in EVAQ Clinical Study for Ischemic Stroke Treatment )

Also on site :

• How Nashville’s Music Row Went MAGA in 2025
• Crew Paints Russian Flag on Oil Tanker Pursued by the U.S. Coast Guard
• FBI Seizes $40 Million Worth of Motorbikes Tied to Top-10 Fugitive